文献速递头颈外科

缺氧诱导肿瘤外泌体通过CCL26调控内皮分泌组促进头颈癌转移

CCL26-Mediated Modulation of Endothelial Secretome by Hypoxia-Induced Tumor-Derived Exosomes Enhances Metastatic Progression in Head and Neck Cancer.
PubMed 文献 · Head Neck · 2026-04-03

本研究探讨缺氧诱导的头颈鳞癌外泌体如何重塑内皮细胞分泌组并促进转移。缺氧外泌体改变HUVEC分泌组中25和52种蛋白,升高CCL26;CCL26增强HNSCC细胞增殖、迁移和侵袭,中和CCL26或抑制其受体CCR3可逆转这些效应。高CCL26和HIF1A与转移、晚期及不良生存相关。

要点

  • 缺氧头颈鳞癌外泌体改变内皮分泌组并升高CCL26。
  • CCL26促进HNSCC细胞增殖、迁移和侵袭,中和CCL26或抑制CCR3可逆转。
  • 高CCL26和HIF1A与转移、晚期及不良生存相关。

核心结论

  • 缺氧诱导肿瘤来源外泌体通过升高CCL26重塑内皮分泌组,促进肿瘤支持表型并驱动HNSCC转移进展。

研究设计与样本

  • 基础研究:使用Detroit-562和FaDu细胞来源的缺氧外泌体处理内皮细胞,结合细胞因子阵列、功能实验、生物信息学及免疫组化分析。

主要发现

  • 缺氧外泌体改变HUVEC分泌组中25和52种蛋白,ELISA证实CCL26升高。
  • CCL26增强HNSCC细胞增殖、迁移和侵袭,中和CCL26或遗传抑制其受体CCR3可消除这些效应。
  • 高CCL26和HIF1A与转移、晚期及不良生存相关。

临床怎么用

  • CCL26-CCR3轴可能作为HNSCC转移干预的潜在靶点,但需进一步临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Tumor cells adapt to hypoxia by releasing hiTDExs enriched with bioactive molecules that modulate endothelial behavior and promote tumor progression. This study aimed to characterize how hypoxia-induced HNSCC exosomes reshape the endothelial secretome and contribute to metastatic potential. METHODS: We examined whether hiTDExs reprogram endothelial cells and alter their secretome using cytokine arrays. Functional assays (migration, invasion, tube formation) showed a tumor-promoting role of CCL26 and tumor-suppressive effects of genetic inhibition of its receptor CCR3, while in silico and immunohistochemistry analyses assessed CCL26, HIF1A, and CD31 expression in relation to metastasis. RESULTS: Hypoxic exosomes from Detroit-562 and FaDu cells altered 25 and 52 proteins in HUVEC secretomes, with elevated CCL26 confirmed by ELISA. CCL26 significantly enhanced HNSCC cell proliferation, migration, and invasion, whereas CCL26 neutralization or genetic inhibition of its receptor CCR3 effectively abrogated these effects. High CCL26 and HIF1A correlated with metastasis, advanced stage, and poor survival. CONCLUSION: hiTDExs reprogram endothelial secretomes by elevating CCL26, promoting tumor-supportive phenotypes and driving metastatic progression in HNSCC.

来源:Head Neck,查看原文。版权归原作者所有。

引用

  1. Capik O, Tekman S, Gundogdu B, et al. CCL26-Mediated Modulation of Endothelial Secretome by Hypoxia-Induced Tumor-Derived Exosomes Enhances Metastatic Progression in Head and Neck Cancer. Head Neck. 2026. PMID: 41928618. doi:10.1002/hed.70259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。